Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06856317

Use of a Smartphone APP for the Management of Postoperative Home Recovery

To calculate the incidence rates of postoperative adverse events (moderate and severe) and rehospitalization in patients undergoing thoracic surgery followed in follow-up using a smartphone application.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

IRCCS Azienda Ospedaliero Universitaria di Bologna

Bologna, Emilia-Romagna, 40138, Italy

Location status: Recruiting

Location contact

Pietro Bertoglio, MD

CONTACT

[email protected]

+051 647 8362

About this study

This is an observational, exploratory, cohort, retrospective study. For this study, data acquired on patients who participated in the trial period of the app will be retrospectively analyzed. Our Operating Unit used the care4today app on a trial basis during the period between March 1 and October 31, 2023, focusing on monitoring the first 30 days after discharge. The app was offered to patients scheduled for thoracic surgery involving access to the pleura. After a few setup questions, the app was activated upon discharge. For the first 15 days it sent daily questions via notification regarding general health status, postoperative pain, respiratory capacity, and resumption of activities. From day 15 to day 30 after discharge, questions were asked every 4 days. All relevant responses were forwarded via e-mail to the clinician in the form of an orange or red alert in relation to lesser or greater severity.

Patients were treated according to clinical practice in accordance with the clinician's judgment and the information in the Data Sheet of each individual product of any concomitant therapies administered according to clinical practice. Informed consent will be collected during follow-ups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged ≥18 years
  • Patients undergoing thoracic surgery
  • Patients who used the care4today app
  • Obtaining informed consent to participate in the study

Exclusion criteria

  • nothing

Treatment and study plan

Primary outcomes

  1. Adverse event rate

    Time frame: 30 days after surgery

    Complications are reported by patients using the mobile phone app.

  2. Moderate adverse event rate

    Time frame: 30 days after surgery

    Complications are reported by patients using the mobile phone app.

  3. Severe adverse event rate

    Time frame: 30 days after surgery

    Complications are reported by patients using the mobile phone app.

  4. Rehospitalization rate

    Time frame: At 30 days from surgery

    Rehospitalization rate in the first 30 days from home discharge.

Secondary outcomes

  1. Non-response rate to questions asked by the application

    Time frame: Throughout the study period, an average of 30 days

    Use of the app

Study contacts

Contact information is provided by the study sponsor or research team.

Pietro Bertoglio, MD

CONTACT

[email protected]

+ 051 647 8362

Sponsors and collaborators

Lead sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Other

Registry information

Official study title

Use of a Smartphone APP for the Management of Postoperative Home Recovery: an Exploratory Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Mar 4, 2025
Registry last updated
Mar 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.